• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长效释药纤维可减轻阿尔茨海默病样发病机制。

Prolonged Drug-Releasing Fibers Attenuate Alzheimer's Disease-like Pathogenesis.

机构信息

Laboratory of Dynamics of Cellular Compartments, Instituto de Pesquisa e Desenvolvimento , Universidade do Vale do Paraiba , Sao Jose dos Campos 12244-000 , São Paulo , Brazil.

Department of Biochemistry, Neurobiology Laboratory, Escola Paulista de Medicina , Universidade Federal São Paulo , São Paulo 04021-00 , Brazil.

出版信息

ACS Appl Mater Interfaces. 2018 Oct 31;10(43):36693-36702. doi: 10.1021/acsami.8b12649. Epub 2018 Oct 22.

DOI:10.1021/acsami.8b12649
PMID:30298718
Abstract

Delivering drugs and agents to the brain is a huge challenge, especially for chronic neurodegenerative disorders, such as Alzheimer's disease (AD). For this, prolonged and sustained release methods to increase brain uptake represent an impacting concept. The bioresorbable polymer poly-lactic acid (PLA) has high potential for medical implants; at the same time, glucagon-like peptide-1 (GLP-1) analogues have considerable neuroprotective attributes and represent a therapeutic strategy for AD. Here, a biodevice is produced by electrospinning PLA with a GLP-1 analogue (liraglutide, LG), coated with a thin layer of gelatin. The biodevice is subcutaneously implanted in a transgenic mouse model of AD and LG is released for 14 days in mice serum. After 4 weeks of implantation, crucial hallmarks of the AD are highly diminished: hippocampal senile amyloid β plaque load and neuroinflammatory markers. Furthermore, neurogenesis is enhanced in the subventricular zone, an important neurogenic niche in the brain. The designed biodevice holds great promise for being an affordable candidate to act as a prolonged drug provider, promoting LG mission through increasing its lifetime, constituting a relevant approach for old and impaired brain.

摘要

将药物和制剂递送到大脑是一个巨大的挑战,特别是对于慢性神经退行性疾病,如阿尔茨海默病(AD)。为此,延长和持续释放以增加大脑摄取的方法代表了一个有影响力的概念。可生物降解的聚合物聚乳酸(PLA)在医学植入物方面具有巨大的潜力;与此同时,胰高血糖素样肽-1(GLP-1)类似物具有相当大的神经保护特性,是 AD 的一种治疗策略。在这里,通过静电纺丝将 PLA 与 GLP-1 类似物(利拉鲁肽,LG)制成生物装置,并涂有一层薄薄的明胶。该生物装置被皮下植入 AD 的转基因小鼠模型中,LG 在小鼠血清中释放 14 天。植入 4 周后,AD 的关键特征大大减少:海马衰老淀粉样β斑块负荷和神经炎症标志物。此外,侧脑室下区的神经发生增强,这是大脑中一个重要的神经发生龛。设计的生物装置具有成为一种负担得起的、可延长药物输送的候选物的巨大潜力,通过延长其寿命来促进 LG 的使命,为老化和受损的大脑提供了一种相关的方法。

相似文献

1
Prolonged Drug-Releasing Fibers Attenuate Alzheimer's Disease-like Pathogenesis.长效释药纤维可减轻阿尔茨海默病样发病机制。
ACS Appl Mater Interfaces. 2018 Oct 31;10(43):36693-36702. doi: 10.1021/acsami.8b12649. Epub 2018 Oct 22.
2
A Novel Bioresorbable Device as a Controlled Release System for Protecting Cells from Oxidative Stress from Alzheimer's Disease.一种新型生物可吸收装置作为一种控制释放系统,用于保护细胞免受阿尔茨海默病氧化应激的损伤。
Mol Neurobiol. 2017 Nov;54(9):6827-6838. doi: 10.1007/s12035-016-0200-0. Epub 2016 Oct 20.
3
Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.GLP-1/GIP 双重激动剂 DA-JC1 与 GLP-1 单一激动剂相比在阿尔茨海默病中的神经保护和修复作用。
Neuropharmacology. 2020 Jan 1;162:107813. doi: 10.1016/j.neuropharm.2019.107813. Epub 2019 Oct 16.
4
Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.在两种阿尔茨海默病转基因APP/PS1小鼠模型中,胰高血糖素样肽-1(GLP-1)受体激动剂利拉鲁肽的长期治疗对β淀粉样蛋白斑块负荷无影响。
PLoS One. 2016 Jul 15;11(7):e0158205. doi: 10.1371/journal.pone.0158205. eCollection 2016.
5
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.利拉鲁肽可逆转老年 APP/PS1 小鼠(阿尔茨海默病模型)的记忆障碍、突触丢失,并减少斑块负担。
Neuropharmacology. 2014 Jan;76 Pt A:57-67. doi: 10.1016/j.neuropharm.2013.08.005. Epub 2013 Aug 21.
6
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease.利司那肽是一种用于治疗2型糖尿病的药物,在阿尔茨海默病小鼠模型中显示出神经保护作用。
Neuropharmacology. 2014 Nov;86:241-58. doi: 10.1016/j.neuropharm.2014.07.015. Epub 2014 Aug 8.
7
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.胰高血糖素样肽-1受体激动剂利拉鲁肽可改善阿尔茨海默病衰老加速小鼠模型的记忆功能并增加海马CA1区神经元数量。
J Alzheimers Dis. 2015;46(4):877-88. doi: 10.3233/JAD-143090.
8
Drugs developed for treatment of diabetes show protective effects in Alzheimer's and Parkinson's diseases.用于治疗糖尿病的药物在阿尔茨海默病和帕金森病中显示出保护作用。
Sheng Li Xue Bao. 2014 Oct 25;66(5):497-510.
9
Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.在淀粉样β蛋白诱导的阿尔茨海默病小鼠模型中,皮下注射利拉鲁肽通过糖原合酶激酶-3β途径调节tau蛋白过度磷酸化,从而改善学习和记忆障碍。
Eur J Pharmacol. 2016 Jul 15;783:23-32. doi: 10.1016/j.ejphar.2016.04.052. Epub 2016 Apr 27.
10
Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.新型咔唑类荧光染料 SLM 对 SH-SY5Y 细胞模型和阿尔茨海默病 3xTg-AD 小鼠模型的神经保护作用。
ACS Chem Neurosci. 2017 Mar 15;8(3):676-685. doi: 10.1021/acschemneuro.6b00388. Epub 2016 Dec 29.

引用本文的文献

1
Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer's Disease.抗糖尿病胰高血糖素样肽-1受体激动剂在阿尔茨海默病实验动物模型中具有神经保护特性。
Pharmaceuticals (Basel). 2025 Apr 23;18(5):614. doi: 10.3390/ph18050614.
2
Long-acting parenteral formulations of hydrophilic drugs, proteins, and peptide therapeutics: mechanisms, challenges, and therapeutic benefits with a focus on technologies.亲水性药物、蛋白质和肽类治疗药物的长效肠胃外制剂:作用机制、挑战及治疗益处,重点关注技术
Drug Deliv Transl Res. 2025 Apr;15(4):1156-1180. doi: 10.1007/s13346-024-01747-y. Epub 2024 Dec 11.
3
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.
胰高血糖素样肽1在阿尔茨海默病和帕金森病中的神经保护作用:深入综述
Front Neurosci. 2022 Sep 1;16:970925. doi: 10.3389/fnins.2022.970925. eCollection 2022.
4
Role of liraglutide in Alzheimer's disease pathology.利拉鲁肽在阿尔茨海默病病理中的作用。
Alzheimers Res Ther. 2021 Jun 12;13(1):112. doi: 10.1186/s13195-021-00853-0.
5
Electrospun Nanofibrous Poly (Lactic Acid)/Titanium Dioxide Nanocomposite Membranes for Cutaneous Scar Minimization.用于减少皮肤瘢痕的静电纺纳米纤维聚乳酸/二氧化钛纳米复合膜
Front Bioeng Biotechnol. 2019 Dec 20;7:421. doi: 10.3389/fbioe.2019.00421. eCollection 2019.